Integrating New Effectiveness Data Into US Food and Drug Administration-Approved Drug Labeling

JAMA Intern Med. 2021 Jul 1;181(7):897-898. doi: 10.1001/jamainternmed.2021.1994.

Authors

Bishal Gyawali^{1

2}, Jonathan J Darrow¹, Aaron S Kesselheim¹

Affiliations

¹ Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
² Division of Cancer Care and Epidemiology, Department of Oncology, Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.

PMID: 33999146
DOI: 10.1001/jamainternmed.2021.1994

No abstract available

MeSH terms

Drug Approval*
Drug Labeling*
Humans
United States
United States Food and Drug Administration